Bitcoin surged this week to touch $97,538 on Wednesday — its highest level in two months. Still, the leading cryptocurrency remains 24% below its October recordBitcoin surged this week to touch $97,538 on Wednesday — its highest level in two months. Still, the leading cryptocurrency remains 24% below its October record

Bitcoin price will pump with these catalysts, experts say

Bitcoin surged this week to touch $97,538 on Wednesday — its highest level in two months. Still, the leading cryptocurrency remains 24% below its October record.

But the asset is “coiled for a decisive move”, according to a report by research firm Kaiko. After the US’ crypto-friendly pivot last year, Bitcoin investors hoping for new heights will have to look beyond Congress and federal regulators, market observers told DL News.

This is what the experts say the big orange coin needs in order to soar again.

The Fed

As usual, when the Federal Reserve makes a move, Bitcoiners listen. Bitcoin has typically done well in a low interest rate environment, and lower rates would help “risk-on” assets like crypto.

Bitcoin’s correlation with tech stocks has been “somewhat elevated” over the past month and, in turn, more susceptible to what the Fed does, Kaiko said.

US President Donald Trump throughout 2025 pressured Fed Chair Jerome Powell to lower interest rates, at one point threatening to fire him. It’s now expected the Republican will appoint a dovish replacement who will follow through on his demands despite the central bank’s supposed independence.

“The catalysts for a new Bitcoin high will be around the loss of Fed independence,” Director of Derivatives at Amberdata Greg Magadini told DL News.

“Without an independent will to fight inflation, the Fed is likely to react too ‘dovishly’ in order to support fiscal spending. This will undermine US dollar fiat and push hard assets — such as BTC — much higher.”

More institutional involvement

Following the approval of spot Bitcoin exchange-traded funds in the US in 2024, some of the world’s largest institutions bought billions of dollars worth of the cryptocurrency. Global banks, hedge funds, and even universities have gained exposure to Bitcoin via the newly approved products.

If this were to resume in 2026, expect the price of the leading digital asset to surge, Bitwise’s European head of research, André Dragosch, told DL News.

“I do think that ongoing institutional adoption could ultimately provide that upside catalyst [for Bitcoin in 2026],” he said.

Things are already changing, pseudonymous CryptoQuant analyst Darkfost told DL News, citing positive flows into Bitcoin ETFs.

This week alone, investors bought $1.6 billion in ETF shares, Darkfost noted. According to JPMorgan, Bitcoin ETFs are on track for their best week since October.

Whales chilling out

Bitcoin whales had a field day in 2025, selling a huge amount of digital coins after the cryptocurrency hit the mythical $100,000 mark, pushing down its price.

But that selling has slowed down — if not completely stopped.

“We can observe that long-term selling has decreased sharply,” Darkfost said, adding that selling pressure coming from the futures market had disappeared.

“The situation has started to evolve, and it is precisely this shift that could pave the way for a more sustainable rally.”

Mathew Di Salvo and Pedro Solimano are correspondents at DL News. Got a tip? Email them at mdisalvo@dlnews.com and psolimano@dlnews.com.

Market Opportunity
Dill Logo
Dill Price(DL)
$0.002123
$0.002123$0.002123
-0.97%
USD
Dill (DL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23